首页> 外文期刊>Acta Obstetricia et Gynecologica Scandinavica: Official Publication of the Nordisk Forening for Obstetrik och Gynekologi >Functional outcome after laparoscopic nerve‐sparing sacrocolpopexy: a prospective cohort study
【24h】

Functional outcome after laparoscopic nerve‐sparing sacrocolpopexy: a prospective cohort study

机译:腹腔镜神经稀释性犯罪后的功能结果:一项潜在的队列研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Introduction To date sacrocolpopexy is regarded as the reference standard treatment for primarily apical compartment prolapse and multicompartment prolapse. Most bladder and bowel dysfunction improves postoperatively after sacrocolpopexy; however, de novo bowel or de novo bladder dysfunction can occur. The inferior hypogastric nerve is commonly known among pelvic surgeons. However, the inferior hypogastric nerve and its fine fibers are difficult to identify; iatrogenic lesion is commonly tolerated although this can lead to bladder, bowel and sexual dysfunction. This study was performed to assess the functional outcome after nerve‐sparing sacrocolpopexy. Material and methods From 2014 to 2016 all women undergoing a laparoscopic sacrocolpopexy for apical or multicompartment prolapse stage 2 were included in this prospective study. Laparoscopic sacrocolpopexy was performed using the nerve‐sparing approach. Objective outcome was assessed by preoperative and postoperative POP ‐Q changes. De novo bladder and de novo bowel dysfunction were subjectively and objectively evaluated. Results In all, 137 women were included. Significant objective improvement for point Aa and C ( p 0.0001) preoperatively to postoperatively was seen. The posterior compartment remained unchanged with point Ba ?2. De novo overactive bladder and de novo bladder outlet obstruction with elevated postresidual volume were seen for both in 0.7% (1/137). De novo stress urinary incontinence was seen in 0.7% (5/137). De novo constipation was seen in 5%, bowel incontinence in 0% and resolution of pre‐existing obstipation in 14.5%. De novo laxative use (9%) in the first 12 weeks was the most common postoperative problem. Conclusion We could demonstrate that when a nerve‐sparing technique is applied for sacrocolpopexy low de novo bladder (18%) and de novo bowel dysfunction can be seen.
机译:摘要迄今为止犯罪的介绍被认为是主要顶级室脱垂和多组分脱垂的参考标准治疗。骶骨后术后大多数膀胱和肠功能障碍都会改善;然而,可以发生De Novo Beasel或De Novo Bladder功能障碍。下哮喘神经是骨盆外科医生的常识。然而,劣质性腹晕和其细纤维难以识别;虽然这可能导致膀胱,肠和性功能障碍,但常见的病变是普遍耐受的。进行该研究以评估神经滥本犯罪后的功能性结果。 2014年至2016年的材料和方法均在这项前瞻性研究中纳入了腹腔镜或多组分脱垂阶段的所有女性腹腔镜脱垂阶段。使用神经备件方法进行腹腔镜骶骨侵扰性。通过术前和术后POP -Q变化评估客观结果。 De Novo Bladder和De Novo Beasel功能障碍主观和客观地评估。结果,包括137名妇女。术后,观察到术后AA和C(P< 0.0001)的显着性能改善。用点BA 2留下后舱保持不变。在0.7%(1/137)中,观察到De Novo过度活性膀胱和具有升高的神经血管体积的膀胱出口梗阻。 De Novo rucal尿失禁在0.7%(5/137)中看到。 De Novo便秘在5%中被观察到5%,排便在0%,并在14.5%的情况下解决了预先存在的备份。在前12周的De Novo泻药使用(9%)是最常见的术后问题。结论我们可以证明,当施用神经制剂技术对于恶毒肝癌低De Novo膀胱(18%)和De Novo肠功能障碍时可以看到。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号